Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samy Hadjadj

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Diabetes Care|June 5, 2008
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studiesSamy Hadjadj, Frédéric Fumeron, Ronan Roussel, et al.
Cardiovascular Diabetology|June 10, 2022
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohortMatthieu Wargny, Mikaël Croyal, Stéphanie Ragot, et al.
Diabetes Care|October 5, 2019
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 DiabetesLouis Potier, Ronan Roussel, Michel Marre, et al.
Cardiovascular Diabetology|October 11, 2022
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetesManuel Sanchez, Caroline Kannengiesser, Sophie Hoang, et al.
ESC Heart Failure|January 13, 2023
Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetesBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Diabetes Technology & Therapeutics|February 17, 2026
Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxia Conditions: A Randomized Controlled Trial-FOX StudyNathanaël Bassas Letissier, Christophe Rault, Corentin Faucher, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 DiabetesMikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Journal of Diabetes and Its Complications|May 17, 2017
Urinary lysophopholipids are increased in diabetic patients with nephropathyJean-Sébastien Saulnier-Blache, Eva Feigerlova, Jean Michel Halimi, et al.
Diabetes Care|July 19, 2013
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuriaGilberto Velho, Nadine Bouby, Samy Hadjadj, et al.
Diabetes Care|August 28, 2020
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO StudyMatthieu Wargny, Pierre Gourdy, Lisa Ludwig, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Diabetes Care|June 5, 2008
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studiesSamy Hadjadj, Frédéric Fumeron, Ronan Roussel, et al.
Cardiovascular Diabetology|June 10, 2022
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohortMatthieu Wargny, Mikaël Croyal, Stéphanie Ragot, et al.
Diabetes Care|October 5, 2019
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 DiabetesLouis Potier, Ronan Roussel, Michel Marre, et al.
Cardiovascular Diabetology|October 11, 2022
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetesManuel Sanchez, Caroline Kannengiesser, Sophie Hoang, et al.
ESC Heart Failure|January 13, 2023
Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetesBarnabas Gellen, Nathalie Thorin-Trescases, Eric Thorin, et al.
Diabetes Technology & Therapeutics|February 17, 2026
Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxia Conditions: A Randomized Controlled Trial-FOX StudyNathanaël Bassas Letissier, Christophe Rault, Corentin Faucher, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 DiabetesMikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Journal of Diabetes and Its Complications|May 17, 2017
Urinary lysophopholipids are increased in diabetic patients with nephropathyJean-Sébastien Saulnier-Blache, Eva Feigerlova, Jean Michel Halimi, et al.
Diabetes Care|July 19, 2013
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuriaGilberto Velho, Nadine Bouby, Samy Hadjadj, et al.
Diabetes Care|August 28, 2020
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO StudyMatthieu Wargny, Pierre Gourdy, Lisa Ludwig, et al.
Pageof 22